Intracerebral giant hydatidosis in an adult woman – A case report

---

Case Report

Author Details : Prakash Mahantshetti, Ravi Ichalakaranji, Suhasini H

Volume : 4, Issue : 3, Year : 2018

Article Page : 160-162

https://doi.org/10.18231/2455-8451.2018.0038

Suggest article by email

Get Permission

---

Abstract

Intracranial hydatid cysts account for 0.5-3% of all the cases of hydatid disease and contribute to 1-2% of all the intracranial space occupying lesions. Rare cases of intracranial hydatid disease have been reported in India. In India, the hydatid disease is more commonly seen in the Kurnool district of Andhra Pradesh, Madurai district of Tamil Nadu and in Punjab.
Here we present a case ofa 35-year-old female patient presented to us with diminution of vision, diplopia tempero- frontal lobe which is T1 hypointense and T2 hyperintense measuring 4.5×5.25cms Patient was subjected for surgical excision of cyst. Post operatively patient improved well with no neurological deficits. Histopathology of the lesion confirmed hydatid cyst. Patient was put on oral albendazole 10mg/kg per day and continued for 12 weeks. Patient is on regular follow up with us, with no neurological deficits. and headache since 10 days. Her neurological assessment showed higher mental functions within normal limit and Visual acuity - 6/12 right eye and 6/9 left eye, with normal fundus & right 6^th cranial nerve palsy. MRI brain (P+C) done was suggestive of intra-axial well defined cystic lesion in right.

Keywords: Intracerebral hydatidosis, Echinococcus, Dowling-Orlando technique, Albendazole

How to cite : Mahantshetti P, Ichalakaranji R, Suhasini H, Intracerebral giant hydatidosis in an adult woman – A case report. IP Indian J Neurosci 2018;4(3):160-162

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.